LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Fundamentals of Biologicals Regulation
Vaccines and Biotechnology Medicines
- 1st Edition - December 1, 2017
- Author: Rebecca Sheets
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 0 9 2 9 0 - 3
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 0 9 4 4 3 - 3
Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines serves as an introduction to the international regulatory arena in which biologicals are developed… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteFundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines serves as an introduction to the international regulatory arena in which biologicals are developed and offers an overview of the processes and insight into the scientific concepts underpinning global regulations. This book will provide multiple levels of readership with guidance on basic concepts, a detailed look at regulatory challenges, and practical insight into how regulators consider regulatory science and regulatory process issues across various regions. With numerous case studies, learning activities, and real-world examples across several classes of biotechnological products, this book is a valuable and comprehensive resource for graduate students, professors, regulatory officials, and industry scientists working with biologicals.
- Provides a broad overview and introduction to the regulatory processes, from product development pathways, through clinical trials and product development stages and beyond
- Includes FDA, EMA, ICH, and WHO recommendations and guidelines so readers can compare and contrast the different regulatory regions with their expectations and understand why they are different
- Contains chapters on some of the exceptions to the process including how biosimilars and in vitro diagnostics are regulated
- Includes numerous case studies, learning activities, and real-world examples across several classes of biotechnological products
Graduate students and professors in biotechnology, pharmaceutical science and regulatory science programs, regulatory officials, industry professionals
Section I: Regulatory Process
1. Introduction2. Discovery and Development of Biologicals3. International Harmonization4. Pre-IND Profess, Guidance from Regulators in Advance of a Clinical Trials Application5. Clinical Trials Approvals and Investigational New Drug Applications6. Marketing Authorization Processes7. Special Regulatory Programs8. Post-Marketing Changes to an Approved Application or Variations9. Compliance and Inspections10. Good "X" Practices
Section II: Regulatory Science
11. Preclinical Safety and Toxicology12. Preclinical Proof-of-Concept and Pharmacology, Animal Use Ethics13. Genetically Modified Organisms and Institutional Biosafety Committees14. Risk Assessments15. Chemistry, Manufacturing, and Controls Information (CMC) and Process Validation16. Analytics, Analytical Validation, Lot Release, and National Control Laboratories17. Regulatory Aspects of Clinical Trials18. Ethics of Clinical Trials and the Informed Consent Process19. Institutional Review Board Processes (Ethics Committees)20. Biosimilars21. In Vitro Diagnostics22. Regulatory Policy and Public Health Policy
- No. of pages: 450
- Language: English
- Edition: 1
- Published: December 1, 2017
- Imprint: Academic Press
- Paperback ISBN: 9780128092903
- eBook ISBN: 9780128094433
RS
Rebecca Sheets
Dr. Sheets is currently a board member and Executive Committee Member (Vice President for Human Biologicals) of the International Alliance of Biologicals Standardization. She is former Vaccine Scientific and Regulatory Specialist at the National Institute of Allergy and Infectious Diseases. Dr. Sheets served 9 years as a Scientific Reviewer in the Viral Vaccines branch of the Division of Vaccines and Related Products Applications at the Center for Biologics Evaluation and Research at the FDA. From 2006-2014, served as Co-Chair of the World Health Organization’s Study Group on Cell Substrates and as Chair of the Adventitious Agents Sub-committee.
Affiliations and expertise
Principal Consultant and Subject Matter Expert, Grimalkin Partners, Silver Spring, MD; Adjunct Professor, Catholic University of America, USARead Fundamentals of Biologicals Regulation on ScienceDirect